GlassScriptPhysician profile
Kevin Daniel White
NPI 1548656630
$1,807.19
in general payments reported to CMS, 2019-2025
20 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2021: $683 · 2022: $681 · 2023: $61.96 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $683.14 | 2021 | |
| Applied Medical Resources Corporation | $512.40 | 2022 | |
| Gen-Probe, INC. | $106.65 | 2019 | |
| Ethicon US, LLC | $72.89 | 2019-2022 | |
| Astellas Pharma US INC | $68.24 | 2023-2025 | Veozah |
| Vertex Pharmaceuticals Incorporated | $43.49 | 2025 | |
| Sage Therapeutics, LLC | $35.20 | 2025 | Zurzuvae |
| Abbvie INC. | $33.37 | 2022 | |
| Myovant Sciences INC. | $32.58 | 2022 | |
| Mayne Pharma Commercial LLC | $28.99 | 2025 | |
| Davol INC. | $24.89 | 2022 | |
| Coopersurgical, INC. | $24.58 | 2019 | |
| Heron Therapeutics, INC. | $22.50 | 2022 | |
| Paratek Pharmaceuticals, INC. | $20.08 | 2025 | Nuzyra |
| Insulet Corporation | $20.00 | 2025 | Omnipod |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $19.35 | 2023 | Korlym |
| Pfizer INC. | $17.44 | 2022 | |
| Indivior INC. | $15.63 | 2023 | Sublocade |
| Axonics, INC. | $13.00 | 2022 | |
| Sumitomo Pharma America, INC. | $12.77 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.